Recruiting OBSERVATIONAL NCT05633706

Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

Evaluation of the Small Intestine Microbiome Aspiration (SIMBA) Capsule for Small Intestinal Dysbiosis

Sponsor: Mitacs

Conditions Celiac Disease Crohn Disease Functional Dyspepsia Healthy Irritable Bowel Syndrome Type 2 Diabetes Ulcerative Colitis

Interventions fluid biopsy capsule

Updated 8 times since 2022 Last updated: Apr 10, 2025 Started: Jan 9, 2023 Primary completion: Jun 6, 2025 Completion: Jun 6, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Celiac Disease and Crohn Disease and is currently actively recruiting participants. Mitacs leads this study, which shows 8 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

May 2025 — Present [monthly]

Recruiting
Sep 2024 — May 2025 [monthly]

Recruiting
Aug 2024 — Sep 2024 [monthly]

Recruiting
Jul 2024 — Aug 2024 [monthly]

Recruiting
Mar 2024 — Jul 2024 [monthly]

Recruiting

▶ Show 3 earlier versions

Apr 2023 — Mar 2024 [monthly]

Recruiting
Feb 2023 — Apr 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Dec 2022 — Feb 2023 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mitacs
Nimble Science Ltd.
University of Calgary

Data source: Nimble Science Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Calgary, Canada